drugset / Trial / NCT03177746

The Safety of Dapoxetine/Tadalafil Combination Therapy

NCT03177746

Phase 4 Unknown 40 enrolled Neutec Ar-Ge San ve Tic A.Ş
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of Dapoxetine/Tadalafil 30/20 mg film-coated tablet in the treatment of men with premature ejaculation and erectile dysfunction.

Timeline

Start
2022-12-31
Primary completion
2023-01-14
Completion
2023-10-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapoxetine Small molecule 30 mg
Subject Tadalafil Small molecule 20 mg